Bombay High Court: Duty-Free Regulatory Laws Apply, Upholds Nicotine Ban

• The Bombay High Court upheld a ban on imported nicotine pouches sold by Adani Group's Mumbai Travel Retail Limited at Mumbai airport due to a lack of an import license.
• The Court ruled that duty-free shops are not exempt from domestic regulatory and public health statutes, such as the Drugs and Cosmetics Act, 1940.
• Exemptions for duty-free shops are limited to fiscal measures like customs duties and taxes, not non-fiscal regulatory oversight.
• Items restricted by any domestic law are considered 'prohibited goods' under the Customs Act of 1962, making the domestic regulatory regime fully applicable.
• The Court directed the Central Drugs Standard Control Organisation (CDSCO) to determine if tobacco-free nicotine pouches are 'drugs' under the Drugs and Cosmetics Act.

The Court's stance clarifies that while certain fiscal benefits apply, these establishments are not entirely immune from national statutes governing public health and product control.

The Bombay High Court has affirmed a decision by the Drugs Control Department to prohibit the sale of imported nicotine pouches by Mumbai Travel Retail Limited, a joint venture involving the Adani Group, at Chhatrapati Shivaji Maharaj International Airport. The prohibition stemmed from the company's failure to possess an adequate import license for the products. This ruling, delivered in the case of Mumbai Travel Retail Ltd v. Union of India & Ors., underscores a critical interpretation of regulatory oversight concerning duty-free operations.

The Division Bench, comprising Justice Suman Shyam and Justice Advait M Sethna, declined to intervene in the department's action. The core of the dispute centered on whether duty-free shops, typically associated with exemptions, are subject to domestic regulatory frameworks. The Court's stance clarifies that while certain fiscal benefits apply, these establishments are not entirely immune from national statutes governing public health and product control.

A pivotal aspect of the High Court's judgment is its unequivocal declaration that duty-free shops (DFS) operating within international departure terminals do not possess blanket immunity from domestic regulatory and public health statutes, specifically citing the Drugs and Cosmetics Act, 1940. The bench emphasized that any exemptions granted to these shops are primarily confined to fiscal measures, such as customs duties, taxes, or MVAT, and do not extend to non-fiscal regulatory oversight.

The Court elaborated that if an item is restricted or prohibited under 'any other law for the time being in force,' it automatically qualifies as 'prohibited goods' under Section 2(33) of the Customs Act of 1962. Consequently, the full force of the domestic regulatory regime applies to such items. This interpretation firmly establishes that the operational environment of duty-free shops, while enjoying certain financial concessions, must still adhere to the broader legal and public health mandates of the country.

While clarifying the applicability of domestic regulatory laws to duty-free operations, the Bombay High Court deliberately refrained from making a definitive determination on whether tobacco-free nicotine pouches should be classified as 'drugs' under the Drugs and Cosmetics Act. Instead, the bench directed the Central Drugs Standard Control Organisation (CDSCO) to undertake this crucial classification.

This directive means that the legality and regulatory pathway for nicotine pouches in India, including their potential sale in duty-free environments, will ultimately hinge on CDSCO's forthcoming decision. The ruling thus sets a precedent for duty-free shops domestic law compliance, indicating that companies operating or supplying these establishments must ensure full adherence to all national product-specific regulations, extending beyond mere fiscal exemptions.

This ruling clarifies that duty-free shops are not exempt from domestic regulatory and public health statutes, requiring companies operating or supplying these establishments to ensure full compliance with all national product-specific regulations. Lawyers and compliance officers should advise clients in this sector to review their compliance frameworks beyond fiscal exemptions and monitor the upcoming CDSCO decision on nicotine pouch classification, which will dictate future product legality.

Source: Original reporting via Bar and Bench